Clinical trial results have shown that Retatrutide, an experimental obesity drug emerging as a competitor to the blockbuster treatments Wegovy and Zepbound, not only reduces weight but is also effective in treating fatty liver, a condition where fat accumulates in the liver
274 A subsequent phase III clinical trial (NCT06183931) will assess its efficacy on the basis of all-cause mortality and cardiovascular events
Please note that the GLP-1 Support Patch has officially been renamed the Berberine Patch
Semaglutide, like any medication, might cause some side effects
A study published in Gastroenterology on March 27, 2024, reports an increased risk of aspiration pneumonia associated with GLP-1RA use during endoscopic procedures with propofol sedation targeting the upper gastrointestinal tract
It is rapidly absorbed in the gastrointestinal tract, leading to peak plasma concentrations within 1 to 3 hours post-ingestion